{
  "id": 657373,
  "title": "India’s pharma exports grew 6.8% in Q1 FY27: Pharmexcil",
  "url": "https://urgent.news/2026/08/12/indias-pharma-exports-grew-6-8-in-q1-fy27-pharmexcil",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-08-12T11:21:34.000Z",
  "source": {
    "name": "Hindustan Times",
    "slug": "hindustan-times",
    "url": "https://www.hindustantimes.com/india-news/indias-pharma-exports-grew-6-8-in-q1-fy27-pharmexcil-101786533694817.html"
  },
  "original_language": "en",
  "account": "India's pharmaceutical exports reached $8.10 billion during the first quarter of FY 2026-27, marking a 6.8% increase compared to $7.58 billion in the same period last year, despite potential US tariff concerns. The Pharmaceuticals Export Promotion Council of India (Pharmexcil) reported this data, highlighting the continued strength of India's pharmaceutical exports in global markets. June exports grew by 7.13% to $2.81 billion, with a 6.86% increase from May's $2.63 billion. Drug formulations and biologicals led exports, contributing $5.98 billion or 73.85% of total exports, while bulk drugs and drug intermediates grew by 13.84% to $1.36 billion. Vaccine exports surged by 35.68% to $0.39 billion, making it the fastest-growing segment. Major export destinations include NAFTA (34.28%), the US (30.89%), and other regions like Europe, Africa, and Latin America. Pharmexcil's chairman, Namit Joshi, emphasized the sector's ability to combine scale in established markets with growth across new geographies, urging continued investments in advanced manufacturing and regulatory compliance to sustain momentum.",
  "summary": "India’s pharmaceutical exports rose 6.8% to $8.1 billion in April-June FY27, with the US remaining the top market, Pharmexcil data showed.",
  "key_points": [
    "India's pharmaceutical exports grew 6.8% in Q1 FY27 to $8.10 billion.",
    "June exports increased by 7.13% to $2.81 billion.",
    "Vaccine exports surged 35.68% to $0.39 billion, fastest-growing segment."
  ],
  "editors_take": "India's pharmaceutical exports growth signals resilience in the face of potential US tariff concerns, with vaccine exports emerging as a particularly strong area of expansion.",
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}